Výsledky vyhledávání

Long-term, prolonged-release oral tapentadol for the treatment of refractory chronic low back pain: a single-center, observational study

Autor: Cristina Deidda, Paolo Mura, Salvatore Sardo, Maurizio Evangelista, Mario Musu, Gabriele Finco, Ida Demelas, Marcello Saba

Publikováno v: Minerva medica. 109(4)

Background Chronic back pain is a leading cause of disability worldwide and it is still inadequately treated. Tapentadol is a dual-acting analgesic drug μ-opioid receptor (MOR) agonist/norepinephrine reuptake inhibitor, carrying a lower risk for opi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bef321cba49239ffd3b0d633d7cbffe
https://pubmed.ncbi.nlm.nih.gov/29947490

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání